These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
874 related articles for article (PubMed ID: 17562543)
1. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. Kaneki H; Kurokawa M; Ide H J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543 [TBL] [Abstract][Full Text] [Related]
2. C-type natriuretic peptide enhances amylase release through NPR-C receptors in the exocrine pancreas. Sabbatini ME; Rodríguez M; di Carlo MB; Davio CA; Vatta MS; Bianciotti LG Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G987-94. PubMed ID: 17702953 [TBL] [Abstract][Full Text] [Related]
3. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B. Thibault G; Grove KL; Deschepper CF Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004 [TBL] [Abstract][Full Text] [Related]
4. Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Inoue A; Hiruma Y; Hirose S; Yamaguchi A; Furuya M; Tanaka S; Hagiwara H Biochem Biophys Res Commun; 1996 Apr; 221(3):703-7. PubMed ID: 8630025 [TBL] [Abstract][Full Text] [Related]
5. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells. Díaz-Troya S; Najib S; Sánchez-Margalet V Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712 [TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948 [TBL] [Abstract][Full Text] [Related]
8. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum. Kim SZ; Kim SH; Park JK; Koh GY; Cho KW J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404 [TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system. Suda M; Tanaka K; Fukushima M; Natsui K; Yasoda A; Komatsu Y; Ogawa Y; Itoh H; Nakao K Biochem Biophys Res Commun; 1996 Jun; 223(1):1-6. PubMed ID: 8660352 [TBL] [Abstract][Full Text] [Related]
10. Presence of functional type B natriuretic peptide receptor in human ocular cells. Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339 [TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells. Sellitti DF; Puggina E; Lagranha C; Doi SQ J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141 [TBL] [Abstract][Full Text] [Related]
12. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B. Hirsch JR; Skutta N; Schlatter E Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393 [TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors. Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396 [TBL] [Abstract][Full Text] [Related]